{"created":"2023-05-15T11:24:02.645800+00:00","id":3773,"links":{},"metadata":{"_buckets":{"deposit":"d4f6c5f3-d9c5-4afa-93c4-13af08fccbc2"},"_deposit":{"created_by":1,"id":"3773","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"3773"},"status":"published"},"_oai":{"id":"oai:showa.repo.nii.ac.jp:00003773","sets":["156:163:301:302"]},"author_link":["12643","12644"],"item_10006_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"関節リウマチ患者における初回メトトレキサート単剤療法後の疾患修飾性抗リウマチ薬の追加を予測する因子の検討"}]},"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2021-03-23"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"昭和大学"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士(薬学)"}]},"item_10006_description_10":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"2020年度"}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"32622甲第3258号"}]},"item_10006_full_name_3":{"attribute_name":"著者(別名)","attribute_value_mlt":[{"nameIdentifiers":[{}],"names":[{"name":"YAMAGUCHI, Takashi"}]}]},"item_10006_relation_16":{"attribute_name":"他の資源との関係","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":".Clin Rheumatol 40(7):2657-2663, 2021"}]}]},"item_10006_select_23":{"attribute_name":"施設","attribute_value_mlt":[{"subitem_select_item":"旗の台校舎"}]},"item_10006_text_22":{"attribute_name":"学部講座部門","attribute_value_mlt":[{"subitem_text_value":"薬/臨床薬学講座/薬物治療学部門"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"山口, 天士"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-05-28"}],"displaytype":"detail","filename":"ko3258_abstract.pdf","filesize":[{"value":"149.9 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ko3258_abstract.pdf","url":"https://showa.repo.nii.ac.jp/record/3773/files/ko3258_abstract.pdf"},"version_id":"11bc632a-ba7a-4f8b-899b-bc4d2575b14a"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-05-28"}],"displaytype":"detail","filename":"ko3258_summary.pdf","filesize":[{"value":"149.9 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ko3258_summary.pdf","url":"https://showa.repo.nii.ac.jp/record/3773/files/ko3258_summary.pdf"},"version_id":"692754fb-5bdd-40c0-b468-db42f71da75d"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-05-28"}],"displaytype":"detail","filename":"ko3258_thesisreview.pdf","filesize":[{"value":"207.2 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ko3258_thesisreview.pdf","url":"https://showa.repo.nii.ac.jp/record/3773/files/ko3258_thesisreview.pdf"},"version_id":"480db38b-37e0-4176-9cda-0263a00a3717"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis"}]},"item_title":"Factors predicting disease-modifying antirheumatic drugs addition after initial methotrexate monotherapy in patients with rheumatoid arthritis","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Factors predicting disease-modifying antirheumatic drugs addition after initial methotrexate monotherapy in patients with rheumatoid arthritis"}]},"item_type_id":"10006","owner":"1","path":["302"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-05-28"},"publish_date":"2021-05-28","publish_status":"0","recid":"3773","relation_version_is_last":true,"title":["Factors predicting disease-modifying antirheumatic drugs addition after initial methotrexate monotherapy in patients with rheumatoid arthritis"],"weko_creator_id":"1","weko_shared_id":1},"updated":"2023-05-15T12:15:11.129875+00:00"}